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Abstract
While the apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii are thought to primarily depend on
glycolysis for ATP synthesis, recent studies have shown that they can fully catabolize glucose in a canonical TCA cycle.
However, these parasites lack a mitochondrial isoform of pyruvate dehydrogenase and the identity of the enzyme that
catalyses the conversion of pyruvate to acetyl-CoA remains enigmatic. Here we demonstrate that the mitochondrial
branched chain ketoacid dehydrogenase (BCKDH) complex is the missing link, functionally replacing mitochondrial PDH in
both T. gondii and P. berghei. Deletion of the E1a subunit of T. gondii and P. berghei BCKDH significantly impacted on
intracellular growth and virulence of both parasites. Interestingly, disruption of the P. berghei E1a restricted parasite
development to reticulocytes only and completely prevented maturation of oocysts during mosquito transmission. Overall
this study highlights the importance of the molecular adaptation of BCKDH in this important class of pathogens.
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Introduction
The phylum of Apicomplexa comprises a large number of obligate
intracellular parasites that infect organisms across the whole
animal kingdom. Two important members of this phylum,
Plasmodium spp. and Toxoplasma gondii, are the etiological agents
of malaria and toxoplasmosis, respectively. Malaria remains one of
the most significant global public health challenges (World Malaria
Report 2012, www.who.int), while toxoplasmosis causes severe
disease and death in immunocompromised individuals and can
lead to complications in development of the foetus if contracted
during pregnancy [1].
Both Plasmodium spp and T. gondii invade a range of mammalian
cells and replicate within a membrane-enclosed compartment
called the parasitophorous vacuole (PV). Residence within the PV
provides protection from host cell defence mechanisms, while
allowing the rapidly developing parasite stages to access small
molecules that can diffuse freely across the PV membrane (PVM)
[2,3]. Both T. gondii replicative forms and Plasmodium blood stages
were thought to rely primarily on glucose uptake and glycolysis for
generation of ATP and other intermediates required for energy
generation and replication [4–8], and to lack a canonical,
pyruvate-fuelled TCA cycle. In particular, Plasmodium-infected
erythrocytes exhibit an extraordinarily high rate of glucose uptake
[9] and selective inhibitors of the Plasmodium hexose transporter are
cytotoxic [10,11]. Moreover, genomic and biochemical studies
have shown that apicomplexan parasites target their single
canonical pyruvate dehydrogenase complex (PDH) to the
apicoplast, a non-photosynthetic plastid organelle involved in
fatty acid biosynthesis, rather than to the mitochondrion [12–14].
The absence of a mitochondrial PDH complex in these parasites
suggested that glycolytic pyruvate was not converted to acetyl-CoA
in the mitochondrion and further catabolised through the TCA
cycle [13–15].
In other organisms, lipids and branched chain amino acids
(BCAA) can be catabolised in the mitochondrion to generate
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acetyl-CoA via pathways not dependent on PDH (Fig. 1A).
However, Plasmodium spp. lack the enzymes needed for the b-
oxidation of fatty acids and BCAA degradation. While T. gondii
retained the enzymatic machinery necessary for b-oxidation,
these parasites appear to lack a typical mitochondrial acyl-
carnitine/carnitine carrier [16,17]. Moreover, the genes
coding for b-oxidation enzymes are apparently not expressed
in tachyzoites, although they may be active in oocysts [18].
The possibility that T. gondii tachyzoites rely on host BCAA
to generate mitochondrial acetyl-CoA was recently investigat-
ed, but disruption of the gene encoding the first enzyme
involved in BCAA degradation, branched chain amino acid
transferase (BCAT) in tachyzoites presented no phenotypic
defect [19]. Together, these studies suggested that there was
minimal synthesis and catabolism of acetyl-CoA in the
mitochondrion.
Several studies have recently led to a reappraisal of this model of
carbon metabolism in Apicomplexa. Firstly, detailed 13C-glucose and
13C-glutamine tracer experiments on T. gondii tachyzoite stages
showed that carbon skeletons derived from both carbon sources
were actively catabolised in a canonical TCA cycle, with the
majority of pyruvate entering via acetyl-CoA. Chemical disruption
of the aconitase enzyme activity, catalysing an early step in the
TCA cycle, completely ablated parasite growth and infectivity in
mammalian cells, indicating that the conversion of citrate to
isocitrate is important for parasite growth and pathogenesis and
that dysregulation of glucose catabolism in the mitochondrion is
likely to be lethal [20]. Second, similar studies undertaken in P.
falciparum indicate that glucose is further catabolised in the
TCA cycle in asexual blood stages [21–23], and at a
dramatically increased rate in sexual gametocyte stages [21].
A functional, canonical TCA cycle capable of generating
reducing equivalents is likely necessary for maintenance of
mitochondrial protein transport and the re-oxidation of inner
membrane dehydrogenases required for pyrimidine biosynthe-
sis [24–28]. The importance of an active respiratory chain in P.
falciparum blood stages is highlighted by the sensitivity of this
stage to the antimalarial drug atovaquone, which targets
respiratory chain complexes [29], and by the increased
expression of TCA cycle enzymes in parasites isolated from
patients in endemic areas [30,31]. Atovaquone is also known to
kill the rapidly dividing tachyzoite and cyst-forming bradyzoite
stages of T. gondii [32].
These studies suggest that the translocation of the conventional
mitochondrial PDH to the apicoplast was associated with a new
enzyme activity that functionally replaced PDH in regulating TCA
cycle metabolism, although the identity of this enzyme remains
unknown. The possibility that other mitochondrial dehydrogenas-
es may individually or collectively fill this missing link was raised
by the finding that the P. falciparum a-ketoglutarate dehydrogenase
(a-KDH) can catalyze the conversion of pyruvate to acetyl-CoA in
vitro, although slightly less efficiently than PDH [33]. On the other
hand, Cobbold et al., proposed that the P. falciparum branched
chain ketoacid dehydrogenase (BCKDH), the only enzyme
implicated in BCAA degradation retained in the Plasmodium spp.,
may substitute for PDH based on the finding that catabolism of
glucose in the TCA cycle in a P. falciparum PDH mutant was
inhibited by oxythiamine, an inhibitor of thiamine pyrophosphate
(TPP)-dependent dehydrogenases [22]. However, oxythiamine
also inhibits a-KDH (and all other TPP-dependent enzymes), and
the enzymatic activity of P. falciparum BCKDH was not tested. The
identity of the enzyme(s) that link glycolysis with mitochondrial
metabolism, and their functional significance in the normal growth
and virulence of these parasites therefore remains an open
question.
The genomes of the apicomplexan parasites that contain a
functional mitochondrion encode all of the subunits of the
BCKDH complex, which include the branched chain a-keto
acid dehydrogenase E1 subunits (EC 1.2.4.4), the dihydrolipoyl
transacylase E2 subunit (EC 2.3.1.168), and the lipoamide
dehydrogenase E3 subunit (EC 1.8.1.4)–(Table S1). The
eukaryotic BCKDH and PDH complexes share many struc-
tural and enzymatic properties, catalysing analogous reactions
in central carbon metabolism where the initial a-ketoacid
is decarboxylated by the E1 subunit - a thiamine diphosphate
(TPP)-dependent heterotetramer consisting of two a
subunits (E1a) and two b subunits (E1b) [34]. Given the
functional similarity between these complexes, we have
previously postulated that the BCKDH complex could have
assumed the function of the mitochondrial PDH in the
Apicomplexa [16].
In this study, we provide unequivocal evidence that BCKDH
primarily fulfils the function of mitochondrial PDH in both T.
gondii and Plasmodium berghei, a rodent model for malaria. P.
berghei allows phenotypic evaluation under physiological
conditions in vivo and offers the potential to interrogate the
whole parasite life cycle from mosquito to mouse. We find that
genetic disruption of the BCKDH-E1a subunit in these
parasites leads to a block in the conversion of pyruvate to
acetyl-CoA, and global changes in metabolic fluxes, as shown
by metabolite profiling and comprehensive 13C-stable isotope
labelling approaches. More importantly, the functional dis-
ruption of the BCKDH multi-enzyme complex was associated
with a growth defect and reduced virulence of T. gondii in mice,
while in P. berghei it resulted in strong alteration of intraeryth-
rocytic development and severely diminished virulence in
mice. In addition, the absence of BCKDH affects all the vector
stages and blocks oocyst development in the mosquito,
indicating that this pathway is essential for transmission of
the disease.
Author Summary
The mitochondrial tricarboxylic acid (TCA) cycle is one of
the core metabolic pathways of eukaryotic cells, which
contributes to cellular energy generation and provision of
essential intermediates for macromolecule synthesis.
Apicomplexan parasites possess the complete sets of
genes coding for the TCA cycle. However, they lack a key
mitochondrial enzyme complex that is normally required
for production of acetyl-CoA from pyruvate, allowing
further oxidation of glycolytic intermediates in the TCA
cycle. This study unequivocally resolves how acetyl-CoA is
generated in the mitochondrion using a combination of
genetic, biochemical and metabolomic approaches. Spe-
cifically, we show that T. gondii and P. bergei utilize a
second mitochondrial dehydrogenase complex, BCKDH,
that is normally involved in branched amino acid catab-
olism, to convert pyruvate to acetyl-CoA and further
catabolize glucose in the TCA cycle. In T. gondii, loss of
BCKDH leads to global defects in glucose metabolism,
increased gluconeogenesis and a marked attenuation of
growth in host cells and virulence in animals. In P. bergei,
loss of BCKDH leads to a defect in parasite proliferation in
mature red blood cells, although the mutant retains the
capacity to proliferate within ’immature’ reticulocytes,
highlighting the role of host metabolism/physiology on
the development of Plasmodium asexual stages.
Role of Mitochondrial BCKDH in T. gondii and T. berghei
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Figure 1. Toxoplasma gondii BCKDH-complex is required for normal growth and virulence. (A) Schematic representation of pathways to
produce acetyl-CoA in the mitochondrion. In green are pathways specific to T. gondii and in red pathways common to T. gondii and Plasmodium spp.
(B) Total lysates from extracellular RHku80_ko (RH) and Tge1a_ko tachyzoites were analysed by Western blot. Expression of BCKDH-E1a was assessed
using polyclonal anti-PfBCKDH-E1a antibodies. Detection of profilin was used as loading control. (C) Plaque assays were performed by inoculating
HFF monolayers with RH or Tge1a_ko parasites for 7 days. Plaques were revealed by Giemsa staining of HFFs. Scale bar represents 1 mm. (D)
Intracellular growth of RH (blue) and Tge1a_ko (red) was assessed after 24 h in complete media, media lacking glutamine, or glucose. Following 24 h
of growth in glucose-depleted environment, glucose was added back to the media and rescue of the parasite’s growth was assessed. Data are
represented as means 6 SD from three independent biological replicates. (E) The apicoplast targeting sequence of TgPDH-E1a (aa 1–225, ABE76506)
and mitochondrial targeting sequence of TgBCKDH-E1a (aa 1–73, XP_002366588) were replaced with the mitochondrial transit peptide of the
superoxide dismutase 3 (SOD3) and myc-tagged [71] to direct the expression of the fusion protein in the mitochondrion of Tge1a_ko parasites for
complementation (creating pTub8-SOD3mycPDHE1a and pTub8-SOD3mycBCKDHE1a respectively). Immunofluorescence assay shows localization of
SOD3mycPDHE1a and SOD3mycBCKDHE1a in the single tubular mitochondrion (anti-myc (in green), anti-GAP45 (pellicle marker in red)). (F)
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Results
Toxoplasma gondii BCKDH is required for normal
intracellular growth and virulence
Point mutations in human BCKDH-E1a are associated with
complete loss of catalytic activity [34], indicating that genetic
depletion of this subunit should be sufficient to abrogate BCKDH
function. Deletion of the gene coding for the E1a subunit of
TgBCKDH was achieved by double homologous recombination
(Tge1a_ko) in the RHku80_ko (hereafter termed ‘RH’) background
strain, which favours homologous recombination over random
integration (Fig. S1A) [35,36]. Transgenic parasites were cloned
and loss of TgBCKDHE1a was demonstrated by genomic PCR
(Fig. S1B), while absence of the protein was confirmed by Western
blot using cross-reacting anti-P. falciparum E1a antibodies (Fig. 1B).
The E1a subunit was detected as a,45 kDa and a,90 kDa band
in Western blots of wild type parasites. The 90 kDa band likely
corresponds to the E1a/E1b heterodimer, as the intensity of this
band was severely diminished under strong denaturating condi-
tions (Fig. 1B). Neither band was detected in the knockout.
The Tge1a_ko formed smaller plaques in a human foreskin
fibroblast (HFF) lytic plaque assay compared to the parental RH
strain (Fig. 1C) indicating a reduced ability to infect and/or grow
in host cells. Further phenotypic analyses revealed that neither
Tge1a_ko tachyzoite invasion nor egress from infected host cells
were affected (data not shown) and that the reduction in fitness was
due to significantly reduced intracellular growth compared to RH
parasites, as monitored by the reduced number of parasites per
vacuole established by Tge1a_ko after 24 h (Fig. 1D). This
phenotype was exacerbated when infected HFF were cultivated
in the absence of glucose in a reversible fashion, while removal of
glutamine did not aggravate this defect (Fig. 1D).
To validate that the phenotypes observed in Tge1a_ko are only
due to the loss of the E1a subunit of BCKDH, we targeted a
second copy of the E1a subunit where the N-terminal mitochon-
drion targeting signal was replaced by the mitochondrial transit
signal of TgSOD3 (SOD3mycBCKDH-E1a, Fig. 1E) in Tge1a_ko
parasites. In addition, we attempted to complement Tge1a_ko
parasites by targeting the product of a second copy of the TgPDH-
E1a subunit to the mitochondrion via replacement of its bipartite
targeting signal with the mitochondrial transit signal of TgSOD3
(SOD3mycPDH-E1a, Fig. 1E). TgPDH-E1a and TgBCKDH-E1a
show significant similarity by sequence alignment (,25%) and the
catalytic residues are clearly conserved between the two subunits
(Fig. S3A). The mitochondrial SOD3mycPDH-E1a was unable to
rescue the intracellular growth defect of Tge1a_ko parasites while
complementation with SOD3mycBCKDH-E1a restored the
growth of Tge1a_ko (Fig. 1F). This highlights a lack of permissive-
ness to interchange subunits between the different a-ketoacid
dehydrogenase complexes but moreover confirmed that the
phenotypes observed with Tge1a_ko are solely due to the absence
of BCKDH activity.
To further examine whether BCKDH is required for virulence,
mice were injected intraperitoneally with ,15 RH or Tge1a_ko
tachyzoites. The inoculation of virulent RH parasites resulted in
acute toxoplasmosis in all mice after 8 days leading to their culling.
In contrast, 3 out of 5 mice infected with Tge1a_ko parasites
remained alive after 21 days (Fig. 1G). The surviving mice had
seroconverted and were resistant to subsequent challenge with
,1,000 RH parasites (Fig. 1G). Taken together, these results
establish that the BCKDH complex is implicated in glucose
catabolism and is important for both parasite fitness in vitro and
virulence in vivo.
BCKDH is required for catabolism of pyruvate in the TCA
cycle of T. gondii
To investigate the underlying basis of the intracellular growth
defect in the BCKDH mutant, T. gondii RH and Tge1a_ko
tachyzoites were cultivated in HFF and metabolite levels in
egressed tachyzoites determined by both GC-MS and LC-MS
(Fig. 2A). Significant differences were observed in the levels of
several glycolytic and early TCA cycle intermediates in Tge1a_ko
tachyzoites, compared to the RH control strain. This included a 4-
to 10-fold decrease in 2-hydroxyethyl-TPP (the intermediate in
synthesis of acetyl-CoA from pyruvate), acetyl-CoA, and citrate,
and a 2- to 4-fold increase in 3-phosphoglycerate (3-PGA),
pyruvate and lactate (Fig. 2A). These data are consistent with a
defect in the conversion of pyruvate to acetyl-CoA and citrate as
well as an increased flux to lactate production.
To confirm that Tge1a_ko parasites have a defect in acetyl-CoA
synthesis, freshly egressed RH and Tge1a_ko tachyzoites were
metabolically labelled with 13C-U-glucose. The intermediates in
glycolysis, the pentose phosphate pathway (PPP) and the TCA
cycle were strongly labelled in RH parasites (Fig. 2B). Citrate
isotopomers were generated containing +2, +3 and +4 13C
carbons, indicative of entry of both 13C2-acetyl-CoA and
13C3-
oxaloacetate derived from pyruvate into the TCA cycle of RH
parasites (Fig. 2D). In contrast, the labelling of acetyl-CoA and
TCA cycle intermediates, including citrate and the C4 dicarbox-
ylic acids, were dramatically reduced in Tge1a_ko (Fig. S2A, 2B
and 2D), suggesting that loss of BCKDH is associated with a block
in entry of glucose-derived pyruvate into the TCA cycle. This was
supported by complementary labelling with 13C-U-glutamine,
which revealed equivalent or elevated enrichment of label in all
TCA cycle intermediates in Tge1a_ko compared to RH parasites
(Fig. 2C). The predominant citrate isotopologue generated in 13C-
glutamine-fed Tge1a_ko had +4 13C atoms (Fig. 2D) indicating that
glutamine-derived 13C4-oxaloacetate combines with a residual
source of unlabelled acetyl-CoA to allow citrate synthesis. This
could reflect low level capacity of the a-ketoglutarate dehydroge-
nase to convert pyruvate to acetyl-CoA, or more likely, the
conversion of mitochondrial-produced 13C4-oxaloacetate to citrate
in the cytosol via the ATP-citrate lyase or the second putative
citrate lyase (TGME49_203110, www.toxodb.org) present in the
genome of T. gondii. Interestingly, significant labelling of glycolytic
intermediates and hexose-phosphate was detected in 13C-gluta-
mine-fed Tge1a_ko tachyzoites, which was absent in wild type
parasites (RH) (Fig. 2C). Collectively, these findings show that the
BCKDH is required for the conversion of pyruvate to mitochon-
drial acetyl-CoA and operation of a cyclical TCA cycle. In the
absence of BCKDH, the continued production of C4 dicarboxylic
acids derived from glutamine by the oxidative TCA cycle leads to
Intracellular growth assay at 32 h post transient transfection of Tge1a_ko with pTub8-SOD3mycPDHE1a, pTub8-SOD3mycBCKDHE1a and pTub8-
mycNtGAP45 (negative control) in complete media or media depleted in glucose. Data are represented as means 6 SD from three independent
biological replicates. Only vacuoles containing parasites transiently expressing the transgene were taken into account. Over 200 vacuoles were
counted per replicate. (G) CD1 mice were infected with RH (in blue) or Tge1a_ko (in red) tachyzoites (,15 parasites per mouse) and survival was
assessed over 21 days. A challenge with ,1000 wild-type RH tachyzoites was performed on mice that survived initial infection and survival followed
for a further 10 days. Five mice were infected per condition.
doi:10.1371/journal.ppat.1004263.g001
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increased gluconeogenic fluxes despite the fact that these parasites
continue to utilize glucose and have a high glycolytic flux.
To investigate whether BCKDH is also required for catabolism
of branched chain amino acids (BCAA), RH and Tge1a_ko were
labelled with 13C-U-leucine, 13C-U-isoleucine and 13C-U-valine.
An untargeted metabolome-wide isotope analysis detected no
significant 13C-enrichment in TCA cycle intermediates, despite
detecting efficient uptake of branched chain amino acids and
conversion to the respective 13C-labeled branched chain keto acids
(data not shown). No significant differences in the steady state
levels of leucine, isoleucine or valine were detected between the
parental and knock out strains (Fig. 2A). Together these data
strongly suggest that mitochondrial acetyl-CoA is not derived from
BCAAs under normal growth conditions (Fig. S2B).
To determine whether the role of BCKDH in acetyl-CoA
production could be by-passed by addition of exogenous acetate,
fibroblasts infected with Tge1a_ko were cultivated in media with or
without acetate. Supplementation of the medium with acetate led
to a partial but significant rescue of the severe growth defect
observed in the absence of glucose (Fig. 2E). This result is
consistent with BCKDH having a role in acetyl-CoA production
and suggests some redundancy in the functions of BCKDH and
acetyl-CoA synthetase in generating mitochondrial and/or cyto-
plasmic pools of acetyl-CoA.
BCKDH is a PDH-like enzyme
In vitro enzyme assays were performed to investigate the
substrate selectivity of T. gondii BCKDH. As attempts to express
an active, recombinant BCKDH complex were unsuccessful,
enzyme assays were performed on whole cell lysates from RH and
Tge1a_ko parasites. PDH activity was detected when cell lysates
were incubated with 0.5 mM pyruvate in the presence of
cofactors, with over two-fold higher concentration of acetyl-CoA
production observed in RH (276 mM) than Tge1a_ko (124 mM)
extracts, confirming a role of BCKDH in acetyl-CoA production
(Fig. 3B) (p,0.05). The significant level of background PDH-like
activity observed in Tge1a_ko extracts is likely mediated by the
apicoplast PDH or mitochondrial a-KDH complexes. Minimal
production of the branched chain acyl-CoAs, 3-methylpropanoyl-
CoA (128 nM) and 3-methylbutanoyl-CoA (below limit of
quantitation; LOQ=5 nM), was detected following incubations
with their respective substrates, 4-methyl-2-oxopentanoate and 3-
methyl-2-oxobutanoate. Branched chain acyl-CoA formation was
significantly lower in Tge1a_ko compared to RH extracts (Fig. 3C–
D), suggesting BCKDH does indeed possess classical BCKDH-like
activity. However, accurate quantification of acyl-CoA products
from assays with higher substrate concentrations (2 mM) con-
firmed that the BCKDH-like activity was 1000- to 10,000-fold
lower than the PDH-like activity (Fig. 3A), suggesting that this
enzyme functions primarily as a PDH in vivo. Interestingly, the
hydroxyalkyl-TPP intermediates for all three substrates were
detected in a BCKDH-dependent manner (Fig. 3E–G).
BCKDH activity is required for correct intraerythrocytic
development of P. berghei
To determine whether BCKDH has a similar role in malaria
parasites, a P. berghei mutant lacking the BCKDH E1a subunit was
generated by double homologous recombination (Pbe1a_ko) (Fig.
S4A). Several independent positive transgenic pools were obtained
after drug cycling. However, their slow growth hampered the
cloning of the mutants by limiting dilution in wild type
immunocompetent CD1 mice. Since the parasites seemed to
exhibit a severe fitness defect that might lead to clearance of the
infection by the mouse immune system, we switched to
immunodeficient RAG-1 -/- mice for cloning purposes [37]. Loss
of expression of Pbe1a in the clonal Pbe1a_ko line from these mice,
was demonstrated by genomic PCR and Western blot analysis
(Fig. S4D and 4A). Strikingly, mice infected with 156106 Pbe1a_ko
parasites had constant low parasitaemias (5–15% over 10 days),
while infection with WT parasites led to an exponential rise in
parasitaemia (up to 45% after 4 days), leading to culling due to
illness (Fig. 4B). Despite having much lower parasitaemias, mice
infected with Pbe1a_ko parasites developed symptoms of severe
anaemia and were culled 10–12 days post-infection (Fig. 4B). The
haematocrit level between the mice infected with WT or Pbe1a_ko
was comparable during the first five days of infection (Fig. 4C).
Haematocrit levels continuously decreased over the subsequent 7
days in the Pbe1a_ko-infected mice (Fig. 4C), consistent with the
observed anaemia in these animals.
To understand why the haematocrit level decreased despite
relatively low parasitaemia, parasite distribution was further
investigated in the different red blood cell types. In wild type
parasite infected mice, parasites could be found both within
reticulocytes as well as in normocytes. In contrast, the majority of
Pbe1a_ko parasites were present within reticulocytes throughout
the course of infection. To assess the importance of this apparent
cell tropism, we induced reticulocytosis in mice with phenylhy-
drazine prior to infection. In mice infected with wild type,
parasitaemia increased as expected and phenylhydrazine pre-
treatment slightly accentuated the growth of the parasites. Pre-
treatment of mice with phenylhydrazine rescued significantly the
growth defect observed with Pbe1a_ko (although not to wild type
levels as reticulocytes maturate into normocytes over the course of
infection) while in mice not pre-treated the parasitaemia levels
remained low throughout the 5 days of infection supporting the
observation that Pbe1a_ko seemed to preferentially infect reticu-
locytes (Fig. 4D). This differential distribution is not explained by
an invasion defect of the Pbe1a_ko parasites for normocytes as
Figure 2. BCKDH is required for conversion of pyruvate to acetyl-CoA and catabolism of glucose in the mitochondrion. Freshly
egressed RH and Tge1a_ko tachyzoites were labelled with 13C-U-glucose or 13C-U-glutamine for 4 h. Abundance and label incorporation were
assessed by GC-MS and LC-MS. (A) Relative (%) abundance of selected metabolites in the TgE1a_ko mutant parasites. Bars represent abundance of
metabolites in Tge1a_ko cells compared with a parental (RH) control. The dashed line refers the abundance of the metabolite in the parental control
(‘100%’). 2HE-TPP refers to 2-hydroxyethyl-thiamine pyrophosphate, the stable intermediate specifically generated by pyruvate dehydrogenase
activity. 2HE-TPP and acetyl-CoA were measured by LC-MS while other metabolites were measured by GC-MS (B) 13C-glucose and (C) 13C-glutamine
incorporation into central carbon metabolites in RH (blue) and Tge1a_ko (red) tachyzoites, where label incorporation is the fraction of molecules of
that metabolite containing one or more 13C carbons (after correction for natural abundance). In A, B and C metabolites are colour-coded by metabolic
pathway; central carbon metabolism, green; TCA cycle and associated amino acids, orange; PPP, purple; other, black. Error bars represent standard
deviation (n = 3–6). Significance as determined by t-test is shown (corrected for multiple comparisons using the Holm-Sidak method), with significant
(p-values of 0.05) differences indicated by an asterisk. { indicates metabolite not detected. (D) Mass isotopologue abundances of citrate generated in
13C-glucose and 13C-glutamine-fed RH and Tge1a_ko tachyzoites. ‘M’ indicates the monoisotopic mass containing no 13C atoms. Error bars indicate
standard deviation (n = 3). (E) Intracellular growth of RH (blue) and Tge1a_ko (red) was assessed after 24 h in medium depleted of glucose
complemented or not with 5 mM exogenous acetate. Data are represented as means 6 SD from three independent biological replicates.
doi:10.1371/journal.ppat.1004263.g002
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shown in (Fig. 4E). Indeed, we observed no difference in invasion
efficiency between WT and Pbe1a_ko parasites when using purified
normocytes and reticulocytes as target host cells.
In vitro maturation was examined following in vitro invasion of
purified normocytes or reticulocytes. This selective distribution
appears to be due to rapid loss of viability of Pbe1a_ko in the
normocytes. Specifically, WT parasites developed to the schizont
stage in both reticulocytes and normocytes (Fig. 4F and 4G,
respectively), whereas Pbe1a_ko parasites developed normally in
reticulocytes (Fig. 4F), but rapidly degenerated within normocytes
(Fig. 4G). Taken together, these findings demonstrate that a
functional BCKDH complex is required for the development of P.
berghei in mature erythrocytes. The abortive infections of normo-
cytes are most likely eliminated from the circulation by the spleen
and liver, resulting in the lower parasitaemia and protracted
course of infection of the mutant.
To confirm that the observed attenuation phenotype is solely
attributable to the deletion of the PbBCKDH-E1a gene, Pbe1a_ko
parasites were complemented with a copy of the P. falciparum
BCKDH-E1a gene, PfE1a (Fig. S4C). Pbe1a_ko+PfE1a parasites
were obtained after several passages in mice with intermittent drug
selection. Integration of the complementation plasmid and PfE1a
protein expression were confirmed by genomic PCR (Fig. S4D)
and Western blot analyses (Fig. S4E). Complementation with
PfE1a restored the ability of these parasites to complete their
development in mature erythrocytes (Fig. 4F and 4G) and their
growth rate in vivo was comparable to the parental WT strain
(Fig. S4F). These results also indicate that the E1a subunit from P.
falciparum can assemble with the P. berghei subunits to form a
functional BCKDH multi-enzyme complex.
BCKDH acts as a PDH-like complex in the mitochondrion
of P. berghei
To determine whether the BCKDH complex fulfils the function
of a mitochondrial PDH in the P. berghei asexual blood stages,
ring/early trophozoite stages of WT and Pbe1a_ko parasite-
infected RBCs (iRBCs) were matured to schizonts in vitro and
labelled with 13C-U-glucose or 13C-U-glutamine over the final 5 h
of maturation. Schizont-iRBCs were purified and the labelling of
intracellular metabolite pools determined by GC-MS. Intermedi-
ates in glycolysis, the PPP and TCA cycle were highly enriched
when RBCs infected with WT parasites were labelled with 13C-
glucose (Fig. 5A and S5A) while in uninfected RBCs, 13C-labelling
from glucose was only detected in the glycolysis and PPP
metabolites (Fig. S5A). After 5 h labelling, the major isotopologues
of citrate in WT iRBCs contained two 13C-carbons, reflecting the
incorporation of 13C2-acetyl-CoA into citrate after one round of
the TCA cycle (Fig. 5B). While a similar labelling of glycolytic and
PPP intermediates was observed in Pbe1a_ko-iRBC, incorporation
into TCA intermediates and associated amino acids was greatly
diminished in the Pbe1a_ko compared to WT iRBCs (Fig. 5A, 5B
and S5A). It is notable that +3 isotopologues of malate and
aspartate (a proxy of oxaloacetate) were still detected in 13C-
glucose-fed parasites, reflecting continued conversion of pyruvate
Figure 3. BCKDH possesses PDH activity. (A) In vitro enzyme activity indicates a low level of classical branched chain keto-acid dehydrogenase
activity and extensive pyruvate dehydrogenase activity in RH T. gondii cell lysates. Concentrations (mean 6 SD) of acetyl-CoA (black), 2-
methylpropanoyl-CoA (grey), and 3-methylbutanoyl-CoA (white columns), were measured following incubation of RH lysates with 2 mM pyruvate
(black), 3-methyl-2-oxobutanoate (grey) or 4-methyl-2-oxopentanoate (white columns), respectively. (B) concentration of acetyl-CoA following in vitro
incubation of RH or Tge1a_ko extracts with 0.5 mM pyruvate (C–D) Relative abundance of acyl-CoA products following in vitro incubation of RH or
Tge1a_ko extracts with 0.5 mM (C) 3-methyl-2-oxobutanoate or (D) 4-methyl-2-oxopentanoate. (E–G) Relative abundance of hydroxyalkyl-TPP
intermediates following incubation of RH or Tge1a_ko lysates with 0.5 mM (E) pyruvate, (F) 3-methyl-2-oxobutanoate or (G) 4-methyl-2-
oxopentanoate. Metabolite intensity (y-axis) is measured by LC-MS peak area (mean 6 SD; n = 2). Significance as determined by t-test is shown, with
p-values of ,0.05 and ,0.01 indicated by an asterisk and double asterisk, respectively.
doi:10.1371/journal.ppat.1004263.g003
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Figure 4. BCKDH is required for growth of Plasmodium berghei in mature RBCs. (A) Total lysates from a mixed population of parasitic stages
for P. falciparum 3D7 (Pf), Pb wild type (WT) and Pbe1a_ko were analysed by Western blot. Expression of BCKDH-E1a (shown by the arrow) was
assessed using cross-reacting anti-PfBCKDH-E1a antibodies. Profilin was used as loading control. (B) Parasitaemia was followed daily in mice infected
with WT (blue line) or Pbe1a_ko (red line). Each line corresponds to the parasitaemia of one mouse. 5 mice were infected per condition. (C)
Haematocrit was followed over the course of infection in mice infected with WT (blue) or Pbe1a_ko (red). Corresponding parasitaemia levels of this
experiment are shown in Fig. S3B. The dotted line represents the mean haematocrit level of uninfected control mice followed throughout the
experiment. Data show mean6 SD from 4 mice per condition. (D) Parasitaemia was followed daily in mice pre-treated (full lines) or not (dotted lines)
with phenylhydrazine to induce reticulocytosis 3 days prior infection with parasites. Mice were infected with 56106 WT (blue line) or Pbe1a_ko (red
line) parasites. 5 mice were infected per condition and lines represent mean parasitaemia6 SD. (E) Invasion of Pbe1a_ko (red) compared to WT (blue).
Vybrant Green-labeled purified schizonts were incubated with DDAO-SE-labeled purified normocytes or reticulocytes, and free merozoites were
allowed to invade. Parasitaemia in the DDAO-SE-labeled target population was determined by flow cytometry. Invasion efficiency was determined as
a percentage of the WT control parasites. Cytochalasin D (CD)-treated schizonts were used as a negative control. Data are represented as mean6 SD
of three independent biological replicates. (F) Giemsa-stained blood smears showing normal development of WT, Pbe1a_ko and complemented
Pbe1a_ko+Pfe1a parasites to the schizont stage in purified reticulocytes. Parasites were cultured in vitro for the times indicated. (G) Giemsa-stained
blood smears showing development of the different strains within purified normocytes. WT parasites mature normally from ring to schizont stage
while Pbe1a_ko degenerate rapidly. Complemented Pbe1a_ko+Pfe1a restored the ability of Pbe1a_ko to develop within normocytes. Parasites were
cultured in vitro for the times indicated.
doi:10.1371/journal.ppat.1004263.g004
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Figure 5. P. berghei parasites lacking the BCKDH-E1a subunit exhibit a perturbed TCA cycle. Cultures containing ring/early-trophozoite
WT and Pbe1a_ko P. berghei-infected RBCs were allowed to mature to schizonts and labelled with 13C-U-glucose or 13C-U-glutamine for 5 hr. Label
incorporation was assessed by GC-MS. (A) Total 13C-glucose-derived label incorporation into central carbon metabolism metabolites in WT (blue) and
Pbe1a_ko (red) P. berghei-infected RBCs, where label incorporation is the fraction of molecules of that metabolite containing one or more 13C carbons
(after correction for natural abundance). Metabolites are colour-coded by metabolic pathway; central carbon metabolism, green; TCA cycle and
associated amino acids, orange; PPP, purple; other, black. Error bars represent standard deviation (N= 4). Significance as determined by t-test is
shown (corrected for multiple comparisons using the Holm-Sidak method), with significant (p-value,0.05) differences indicated by an asterisk. {
indicates metabolite not detected. (B) Mass isotopologue distributions of the TCA intermediates shown in Panel A. The x-axis indicates the number of
13C-atoms in each metabolite (‘M’ indicates the monoisotopic mass containing no 13C atoms). The y-axis indicates fractional abundance of each
isotopologue when labelled with 13C-U-glucose (present in the culture medium at ,50%). Error bars indicate standard deviation (N= 4). (C, D) As for
A and B, but after labelling with 13C-U-glutamine (present in the culture medium at ,98%).
doi:10.1371/journal.ppat.1004263.g005
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to malate (via oxaloacetate) by the action of PEPC (Fig. 5B), as
recently observed [23]. These findings demonstrate that BCKDH
is required for the mitochondrial catabolism of glucose by
conversion of pyruvate to acetyl-CoA in P. berghei blood stage
parasites.
Importantly, both wild type and Pbe1a_ko-infected RBC
catabolized 13C-U-glutamine in a canonical TCA cycle (Fig. 5C
and 5D), as has recently been shown to occur in P. falciparum [21–
23]. However, in contrast to the situation in T. gondii, no evidence
for increased gluconeogenesis in the Pbe1a_ko-infected RBC was
observed, consistent with the absence of key gluconeogenic
enzymes in these parasites [10].
As anticipated, label derived from 13C-U-leucine was not
incorporated into TCA cycle intermediates in either WT,
Pbe1a_ko-infected RBC, or uninfected RBCs (Fig. S5B), indicating
that PbBCKDH does not catabolise a-ketoacids generated from
BCAA and consistent with the absence of BCAA-specific
aminotransferase (BCAT) in the malaria parasite genomes (Table
S1).
To assess whether differences in the acetyl-CoA levels of
Pbe1a_ko, via conversion of acetate to acetyl-CoA from the acetyl-
CoA synthetase, could be responsible for the reticulocyte tropism
that is observed, we followed in vitro maturation of wild type and
Pbe1a_ko parasites within normocytes in presence or not of
exogenous acetate. Pbe1a_ko parasite growth in normocytes was
partially restored by supplementation of the medium with acetate
(Fig. 6A–B and S6A), indicating that the presence of acetate in
reticulocytes could be one of the factors contributing to the ability
of Pbe1a_ko parasites to survive and develop within this cell type
but not within normocytes.
BCKDH has roles in P. berghei sexual development and
oocyst maturation
We next assessed the effect of deleting the BCKDH-E1a gene on
sexual development and mosquito transmission of P. berghei. To
minimise a potential indirect effect of the attenuated growth of the
Pbe1a_ko mutant on gametocyte numbers, mice were injected with
phenylhydrazine two days before infection, inducing mild anaemia
and increased reticulocytosis. As a result, a similar parasitaemia
was obtained for all strains on day 3 post-infection (Fig. 7A). The
numbers of morphologically mature female (macro-) and male
(micro-) gametocytes were lower in Pbe1a_ko parasites than in
either wild type or PfE1a complemented clones (Fig. 7A). The
small number of microgametocytes in the Pbe1a_ko clone had a
considerably reduced capacity to differentiate (exflagellate) into
microgametes when stimulated by xanthurenic acid in vitro.
Figure 6. Acetate complementation of P.berghei BCKDH null mutants. (A) Following in vitro invasion of normocytes with WT or Pbe1a_ko,
parasites were allowed to mature in vitro for 20 h in media supplemented or not with 5 mM acetate. Replication of DNA content was taken as
measure of parasite maturation. DNA was labelled using Vybrant DyeCycle Ruby Stain and fluorescence intensity was measured by flow cytometry.
Highlighted in green is the ring/parasites degenerated early in their development fraction while trophozoite/schizont stage iRBCs are highlighted in
orange. The results of two other biological replicate can be found in Fig. S6. (B) Giemsa-stained blood smears showing development of the different
strains within normocytes in medium complemented or not with 5 mM acetate. WT mature from ring to schizonts within normocytes in presence of
5 mM acetate. Pbe1a_ko degenerate rapidly within normocytes in normal culture conditions while complementation with 5 mM acetate rescues
partially their viability and maturation. Figure shows the various stages of Pbe1a_ko maturation that can be observed over the in vitro culture period.
Parasites were cultured in vitro for the times indicated.
doi:10.1371/journal.ppat.1004263.g006
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Figure 7. Role of BCKDH during sexual development and in mosquito stages of P. berghei. (A) Asexual parasitaemia and male (micro-) and
female (macro-) gametocytaemia in the peripheral blood of mice 3 days post infection with 16107 parasites i. p. Error bars show standard deviations
from 3 mice. (B) Developmental capacity of gametocytes in vitro measured from the same infections shown in panel A. The relative ability of
microgametocytes to release microgametes was assessed by counting exflagellation centres in a haemocytometer 15 min after addition to activating
medium. The ability of activated macrogametocytes to become fertilised and convert to ookinetes was assessed by quantifying round and ookinete-
shaped parasites following life staining of the surface marker P28. Colour code as in panel A; error bars show standard deviations. (C) Oocyst numbers
on the midguts of individual A. stephensi mosquitoes on different days after feeding on three infected mice per mutant. Geometric means and 95%
confidence intervals are also shown. (D) Sizes of individual oocysts from infected midguts at different days after infection. Black lines show geometric
means and 95% confidence intervals. (E) Fluorescence micrographs of representative A. stephensi midguts dissected 14 days after feeding on wild
type and mutant parasites expressing GFP. Scale bar = 0.5 mm. (F) Phase contrast images of representative oocysts. Scale bar = 10 mm. (G) Sporozoite
numbers per mosquito as determined from 3 batches of 10 dissected salivary glands. Transmission from mosquito to mice was examined by
measuring the prepatent period in 2 mice per group after bites from ,20 mosquitoes or intraperitoneal injection of homogenates from 10 pairs of
salivary glands. Data shown in all panels are representative of two independent experiments each performed with three infected mice per parasite
line.
doi:10.1371/journal.ppat.1004263.g007
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Possibly as a result, the ability of macrogametocytes to convert into
ookinetes upon activation in vitro was also reduced (Fig. 7B).
Absence of BCKDH thus reduced both the numbers of
morphologically mature gametocytes and their ability to develop
in vitro.
To assess the role of BCKDH in transmission, Anopheles stephensi
mosquitoes were allowed to feed on infected mice. Consistent with
the in vitro data, the Pbe1a_ko mutant gave rise to a considerably
reduced number of oocysts per infected mosquito midgut, an effect
that was fully reversed by complementation with the PfE1a gene
(Fig. 7C). Importantly, after day 7 of infection, Pbe1a_ko showed a
marked inability to increase in size (Fig. 7D and 7E), and the
mutant cysts invariably failed to undergo sporogony (Fig. 7F).
Pbe1a_ko-infected mosquitoes contained no sporozoites in their
salivary glands on day 21 post infection, neither were they able to
re-infect mice, either by bite or intravenous injection of disrupted
salivary glands (Fig. 7G). Taken together, these data demonstrate
that in addition to its role for blood stage development in
normocytes, BCKDH is necessary for normal gametocyte
production and fitness, and that BCKDH is essential for oocysts
to mature and undergo sporogony.
Discussion
Using a combination of genetic and metabolomic approaches,
we show that the BCKDH complex not only substitutes for the loss
of mitochondrial PDH in Apicomplexa, but is also required for
normal growth and virulence of T. gondii and P. berghei. While T.
gondii and Plasmodium spp. were thought to depend on glycolysis for
energy, recent studies have highlighted the potential importance of
oxidative phosphorylation and mitochondrial metabolism
[27,28,30,38]. Indeed 13C-glucose and 13C-glutamine labelling
studies have recently confirmed the operation of a canonical TCA
cycle in both T. gondii and P. falciparum [20,21]. A critical question
raised by these studies concerns the identity of the enzyme(s) that
feed carbon skeletons into the TCA cycle. In most organisms, the
operation of the TCA cycle is dependent on production acetyl-
CoA from pyruvate, via the catalytic activity of a mitochondrial
PDH complex. Apicomplexa have a canonical PDH, but this
complex is targeted to the apicoplast, suggesting that other
enzymes fulfil the function of the PDH in the mitochondrion [13–
15]. Recent studies have raised the possibility that mitochondrial
acetyl-CoA could be generated from glycolytic pyruvate via one of
the other TPP-dependent mitochondrial dehydrogenases [22,33].
However, direct evidence for involvement of either BCKDH or a-
KDH, or another uncharacterized dehydrogenase has not been
obtained.
Here, we have generated T. gondii and P. berghei BCKDH null
mutants by reverse genetics and demonstrated loss of mitochon-
drial glucose metabolism. Deletion of the BCKDH-E1a gene from
T. gondii and P. berghei was non-lethal, but in each case led to a
marked reduction in growth rate and impacted on parasite
virulence in mice. Metabolite profiling coupled with 13C-U-
glucose labelling established that BCKDH catalyses the conversion
of mitochondrial pyruvate to 13C2-acetyl-CoA and fuels a
canonical TCA cycle both in T. gondii and P. berghei. Specifically,
deletion of BCKDH-E1a was associated with loss of labelling of
13C2-acetyl-CoA and +2 13C-isotopologues of other TCA cycle
intermediates. In T. gondii, loss of the BCKDH-E1a gene also led to
significant decreases in 2-hydroxyethyl-TPP, the intermediate in
acetyl-CoA production from pyruvate, as well as acetyl-CoA and
citrate. Conversely, pyruvate levels increased in a manner
consistent with this substrate no longer being consumed by the
enzyme. In vitro analysis of a-ketoacid dehydrogenase activity in
T. gondii extracts demonstrated some affinity for both pyruvate and
branched-chain keto-acids, but with a high selectivity for the
conversion of pyruvate to acetyl-CoA compared to the minimal
conversion of branched chain keto-acids to their respective
branched chain acyl-CoA products. Taken together, our data
demonstrate that the apicomplexan BCKDH complex has been
repurposed to function as a PDH and allow the further oxidation
of pyruvate in a canonical TCA cycle.
Sequence alignment analysis of the T. gondii and P. berghei E1a
with other BCKDH-E1a (Fig. S3B and S3C) and E1b subunits
failed to ascertain whether active site residue substitutions can
account for substrate versatility [39,40] and further structural
characterization will be required to refine our understanding of the
substrate specificity of this class of enzyme. However, these results
account for the retention of BCKDH genes in Plasmodium spp.,
despite the loss of other genes involved in BCAA degradation.
They are also consistent with the presence of the two genes coding
for the subunits of the mitochondrial pyruvate carrier recently
described in yeast [41,42] (Table S1). Interestingly, more distantly
related members of the Alveolata, such as dinoflagellates also lack a
conventional mitochondrial PDH complex, but retain a BCKDH
[17], suggesting that the repurposing of BCKDH evolved early in
the evolution of this group and is likely to be conserved in all
members of this group that contain a functional TCA cycle.
Intriguingly, the disruption of the BCKDH enzyme complex
was associated with significant remodelling in the central carbon
metabolism in T. gondii (Fig. 8). Metabolic profiling of Tge1a_ko
parasites revealed that despite a decrease in citrate, other TCA
cycle metabolites including the C4-dicarboxylic acids succinate,
fumarate and malate were all unaltered or even increased in
abundance, indicating that an alternative carbon source enters the
TCA cycle below a-ketoglutarate. T. gondii tachyzoites co-utilize
glutamine in the presence of glucose and appear to use this amino
acid as an alternative substrate in the absence of glucose [43].
Unexpectedly, we found that carbon skeletons derived from 13C-
glutamine were channelled into the gluconeogenic pathway in
Tge1a_ko parasites under glucose-replete conditions (Fig. 2C and
8). This metabolic perturbation is not due to interruption of the
early steps in the TCA cycle or increased glutaminolysis, since
increased gluconeogenic flux is not observed in parasites treated
with sodium fluoroacetate, an inhibitor of the TCA cycle enzyme
aconitase [20]. Increased gluconeogenesis in Tge1a_ko might result
from allosteric activation of key enzymes, as a result of the
accumulation of pyruvate or other metabolites. Alternatively, the
decreased production of acetyl-CoA in the mutant could lead to
global changes in the acetylation state of multiple enzymes in these
pathways [44–46]. The gluconeogenic enzyme, phosphenolpyr-
uvate carboxykinase (PEPCK) is activated by deacetylation [47],
and this enzyme has been shown to be acetylated in T. gondii
tachyzoites, as is cytosolic glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) [48]. Bacterial acetylated GAPDH has been
reported to drive the forward reaction during glycolysis, while it is
more active in catalysing the reverse reaction used in gluconeo-
genesis when deacetylated [45]. A global decrease in protein
acetylation as a consequence of blocked acetyl-CoA synthesis
could therefore underlie the inappropriate activation of gluconeo-
genesis in Tge1a_ko (Fig. 8).
The phenotypic analyses of the BCKDH null mutant revealed
an important impact on the physiology of the blood stages of the
rodent malaria parasite. In contrast to other P. berghei mutants with
defects in central carbon metabolism, such as the mitochondrial
complex II (succinate-ubiquinone reductase) [28] and the type II
NADH:ubiquinone oxidoreductase (NDH2) [27], the Pbe1a_ko
mutant exhibited an obvious phenotypic defect during asexual
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development in mature red blood cells. Pbe1a_ko parasites readily
invaded reticulocytes and normocytes, but failed to develop to
schizonts in the latter. While the molecular basis for the selective
growth in reticulocytes compared to normocytes is unknown, it is
likely that differences in the metabolism of these two host cell types
contribute to the observed tropism. In particular, reticulocytes are
known to be metabolically more active than normocytes, and may
contain essential metabolites that could compensate for the loss of
BCKDH function [49,50]. In support of this conclusion, Pbe1a_ko
parasite growth in normocytes was partially restored by
supplementation of the medium with acetate (Fig. 6 and 8),
indicating that the mutant is able to scavenge acetate or other
essential nutrients from reticulocytes in order to survive in the
absence of BCKDH. Alternatively, intrinsic- and parasite-induced
differences in the permeability of the reticulocyte/normocyte
plasma membrane [51–53] could lead to a differential accumu-
lation of toxic compounds, such as lactate and pyruvate, and
lethality in the Pbe1a_ko strain. These findings also raise the
question of the importance of BCKDH for each of the different
human malaria parasite species, given that P. falciparum can
Figure 8. Proposed metabolic pathways, compartmentalisation and metabolic remodelling in T. gondii and P. berghei. (A) Schematic
representation of the metabolism in T. gondii WT (left panel) and Tge1a_ko (right panel) incorporating data from this study. (B) Scheme of the
metabolism in P. berghei WT (left panel) and Pbe1a_ko (right panel). For both (A) and (B), the remodelling of the parasites metabolism upon ablation
of BCKDH activity is highlighted in green. Dotted lines represent drops and disruption in the corresponding reactions. Abbreviations: AcCoA, acetyl-
CoA; a-KG, a-ketoglutarate; Cit, citrate; Glc, glucose; Glu, glutamate; Gln, glutamine; Lac, lactate; Mal, malate; OAA, oxaloacetic acid; PEP,
phosphoenolpyruvate; Pyr, pyruvate; Suc, succinate. Enzymes in red: BCKDH, branched chain keto acid dehydrogenase; ACL, ATP-citrate lyase; ACS,
Acetyl-CoA synthetase; CS-II, second isoform of citrate synthetase.
doi:10.1371/journal.ppat.1004263.g008
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develop in both immature and mature erythrocytes, whereas P.
vivax exhibits a strict preference for reticulocytes [54] and
establishes a chronic infection in the liver [55].
We have recently shown that flux of pyruvate derived from
glucose into the TCA cycle increases markedly as P. falciparum
asexual RBC stages differentiate to gametocyte stages, implying
that the steps catalysed by BCKDH may be regulated in a stage-
specific manner [21]. Consistent with an increased role for P.
falciparum BCKDH in sexual development, the P. berghei BCKDH-
E1a mutant exhibited a reduction in both numbers and fitness of
gametocytes. Both phenotypes were reversed by complementing
the mutant with an orthologous gene from P. falciparum. While a
reduction in gametocyte numbers alone would be difficult to
interpret given the different infection courses of wild type and
mutant parasites, a reduction in the ability of each microgame-
tocyte to release microgametes and of macrogametes to convert to
ookinetes is highly significant. Our phenotype is clearly less severe,
but otherwise resembles that described by [28] in P. berghei for a
mutant in mitochondrial complex II, predicted to have a disrupted
TCA cycle downstream of both glucose and glutamine. These data
are entirely consistent with a key role for BCKDH in a glucose-
fuelled TCA cycle that in P. berghei increases in importance during
sexual development.
The P. berghei BCKDH-E1a is essential for transmission through
mosquitoes as it is required for sporogony, a period when the
young oocysts grow rapidly in size and differentiate into thousands
of sporozoites. Oocyst growth was also blocked in an NDH2-
deficient P. berghei mutant [27], further highlighting the impor-
tance of oxidative phosphorylation during these stages of parasite
development. Together, our data suggest that BCKDH plays a key
role in the stage-specific changes in flux of glycolytic pyruvate into
the TCA cycle in mosquito stages.
This study highlights the metabolic adaptations that have
occurred during the evolution of this diverse group of protists and
provides new insights into the central carbon metabolism of key
pathogenic stages. Since perturbation of mitochondrial metabo-
lism results in significant decrease in parasite fitness in the
mammalian host and inhibition of vector transmission, compo-
nents of the BCKDH complex may be suitable targets for drug
development.
Materials and Methods
Ethics statement
All animal experiments were approved and performed in
accordance with a project licence issued by the UK Home
Office and by the Direction ge´ne´rale de la sante´, Domaine de
l’expe´rimentation animale (Avenue de Beau-Se´jour 24, 1206
Gene`ve) with the authorization Number (1026/3604/2, GE30/
13) according to the guidelines set by the cantonal and
international guidelines and regulations issued by the Swiss
Federal Veterinary Office.
No human samples were used in these experiments. Human
foreskin fibroblasts (HFF) were obtained from ATCC.
Antibodies
The antibodies used in this study were described before as
follows: mouse monoclonal anti-myc (9E10), polyclonal rabbit
anti-GAP45 [56], rabbit anti-PfProfilin [56]. For the production of
specific polyclonal antibodies, PfBCKDH-E1a sequence
(PF13_0070, aa 277 to 425) was amplified using primers 2391
and 2392 (Table S2) and cloned into pETHb in frame with 6
histidine residues between the NcoI and SalI restriction sites. The
corresponding recombinant protein was expressed in Escherichia coli
BL21 strain and purified by affinity chromatography on Ni-NTA
agarose (Qiagen) according to the manufacturer’s protocol under
denaturing conditions. Antibodies against PfBCKDH-E1a were
raised in rabbits by Eurogentec S.A. (Seraing, Belgium) according
to their standard protocol.
Immunofluorescence assay (IFA) and Western blots analysis
with these antibodies were performed as previously described [33].
T. gondii strains and culture
T. gondii tachyzoites (RHku80_ko (RH), RHku80_ko/bckdhE1a_ko
(Tge1a_ko)) were maintained in HFF using Dulbecco’s Modified
Eagle’s Medium (DMEM, GIBCO, Invitrogen) supplemented
with 5% foetal calf serum, 2 mM glutamine and 25 mg/ml
gentamicin at 37uC and 5% CO2.
Generation T. gondii Tge1a_ko
2 kb genomic flanking sequences (FS) of TgBCKDH-E1a
(TGME49_239490, www.toxodb.org) ORF were amplified using
LATaq polymerase (TaKaRa) and primers 2821 and 2822 for the
5’FS and primers 2823 and 2824 for the 3’FS (Table S2).
Amplified regions were then cloned into the KpnI, XhoI sites for the
5’FS and BamHI, NotI sites for the 3’FS of the pTub5HXGPRT
vector. T. gondii RHku80_ko tachyzoites were transfected by
electroporation as previously described [57] and stable transfec-
tants were selected for by hypoxanthine-xanthine-guanine-phos-
phoribosyltransferase (HXGPRT) expression in the presence of
mycophenolic acid and xanthine as described earlier [58].
Parasites were cloned by limiting dilution in 96 well plates and
clones were assessed by genomic PCR and Western blot analysis.
Phenotypic analyses
Plaque assays: HFF monolayers were infected with parasites and
let to develop for 7 days before fixation with PFA/GA and Giemsa
staining (Sigma-Aldrich GS500) mounted with Fluoromount G
and visualized using ZEISS MIRAX imaging system equipped
with a Plan-Apochromat 206/0.8 objective at the bioimaging
facility of the Faculty of Medicine, University of Geneva.
Intracellular growth assays: Prior to infection, the HFF
monolayers were washed and pre-incubated for 24 h with medium
containing the relevant carbon source and kept in this medium for
the rest of the experiment. Complete medium is DMEM 41966
(Gibco, Life Technologies) supplemented with 5% FCS, up to
6 mM glutamine, 25 mg/ml gentamicine. Medium depleted in
glutamine is DMEM 11960 supplemented with 25 mg/ml
gentamicine (Gibco, Life Technologies) and medium depleted in
glucose is DMEM 11966 supplemented with up to 6 mM
glutamine and 25 mg/ml gentamicine. HFF were inoculated with
parasites and coverslips were fixed 24 h post-infection with 4%
PFA and stained by IFA with rabbit anti-TgGAP45, mouse anti-
myc 9E10. Number of parasites per vacuole was counted in
triplicates for each condition (n= 3). More than 200 vacuoles were
counted per replicate.
In vivo virulence assay
On day 0, mice were infected by intraperitoneal injection with
either wild type RH or Tge1a_ko parasites (,15 parasites per
mouse). 5 female CD1 mice were infected per group. The health of
the mice was monitored daily until they presented severe
symptoms of acute toxoplasmosis (bristled hair and complete
prostration with incapacity to drink or eat) and were sacrificed on
that day in accordance to the Swiss regulations of animal welfare.
21 days post-infection, sera from mice that survived primary
infection were assessed for seroconversion by Western blot for the
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presence of anti-T. gondii antibodies. Mice were then challenged
with ,1000 wild-type RH parasites to assess immunization and
survival.
Plasmodium berghei culturing
The P. berghei ANKA GFP-con clone 2.3.4 was used to generate
transgenic parasites and maintained in female CD1 or Theiler’s
Original outbred mice as described previously [59]. The course of
infection was monitored on Giemsa-stained tail blood smears.
Generation of P. berghei transgenic line
PbBCKDH-E1a sequence was retrieved from the online Plasmo-
dium genome database, (PBANKA_141110, www.plasmodb.org).
To generate the PbBCKDH-E1a knockout (Pbe1a_ko), primers
3835 and 2482 were used to amplify a 2 kb region of homology at
the 5’end of the PbBCKDH-E1a locus (Table S2). The PCR
fragment was cloned between KpnI and ApaI restriction sites of the
pBS-DHFR vector containing the T. gondii dhfr conferring
pyrimethamine resistance [60]. The 3’ flanking region 2 kb was
amplified using primers 3836 and 2483 and cloned between
EcoRV and BamHI restriction sites of pBS-DHFR. The final
construct was linearized with NotI prior to transfection.
Complementation of Pbe1a_ko by P. falciparum BCKDH-E1a was
performed using a knock-in strategy in the promoter region of
PbBCKDH-E1a still present in Pbe1a_ko parasites. Primers 4067
and 4068 were used to amplify this promoter region and the PCR
(pPbE1a) fragment was cloned between the NotI and ApaI sites of
pARL-GFP-Ty-hDHFR. Primers 4070 and 4256 were used to
amplify the PfBCKDH-E1a cDNA (PF3D7_1312600, www.
plasmodb.org) and cloned between the ApaI and NcoI of the
pPbE1a-GFP-Ty-hDHFR. Finally, the 3’UTR of PbBCKDH-E1a
was amplified using primers 4257 and 4258 and the PCR
fragment cloned between the NcoI and EcoRV sites of pPbE1a-
PfE1a-Ty-hDFR in order to generate the final plasmid, pPbE1a-
PfE1a-3’PbE1a-hDHFR. This plasmid was linearized by MfeI
prior transfection in Pbe1a_ko strain.
Transfections were carried out as previously described [61].
Briefly, after overnight culture of infected red blood cells (37uC,
90 rpm), mature schizont-infected RBC were purified by Nyco-
denz gradient and collected. 100 mL of Human T Cell
Nucleofector Kit (Amaxa) and 15 mg of digested DNA. Electro-
poration was performed using the U33 program of the
Nucleofector electroporator (Amaxa/Lonza). Electroporated par-
asites were mixed with blood enriched in reticulocytes from
phenylhydrazine-treated mice to allow re-invasion and immedi-
ately injected (intraperitoneal) into CD1 female mice. Mice
were treated with pyrimethamine in drinking water (conc.
Final = 0.07 mg/ml), 24 hr after infection. After 3 drug-cycling,
infected blood was collected and P. berghei genomic DNA was
extracted with SV Wizard Genomic DNA kit (Promega). Pbe1a_ko
pools were cloned in RAG-1 -/- mice by limiting dilution. The
integration of the different constructs was confirmed by genomic
PCR, using primers listed in table S2 and loss or presence of the
protein was validated by Western blot analysis.
Reticulocyte purification and invasion assay of
Plasmodium berghei
After separation of the plasma from red blood cells and washes
in RPMI by centrifugation (3006 g for 10 min), mouse
reticulocytes were separated from normocytes by Percoll/NaCl
density gradient (1.096–1.058 g/mL) and centrifuged at 2506 g
for 30 min, as previously described [62,63]. Reticulocytes were
collected from the interface of the two Percoll layers and washed
twice with RPMI before culturing. Invasion efficiency in
normocytes or purified reticulocytes was assessed by flow
cytometry as previously described [64].
Haematocrit
Haematocrit levels were observed in mice over the course of
infection with P. berghei wild type and Pbe1a_ko parasites. Briefly,
every two days, haematocrit-capillaries (Hirschmann Laborgera¨te,
75 mm/18 mL, ammonia heparinized 0,9 IU/capillary) were
filled with tail blood and centrifuged at 10,000 rpm for 5 min to
separate the blood layers. Percentage haematocrit was calculated
by dividing the packed red blood cell volume length by the total
blood volume length (red blood cells and serum).
P. berghei phenotyping through the life cycle
The mice used for the phenotyping were pretreated with 150 ml
of 6 mg/ml of phenylhydrazine and infected with 107 parasites
two days later. Three days after infection parasitaemia and
gametocytaemia were quantified on Giemsa-stained thin blood
smears. To quantify exflagellation rates 10 ml blood collected from
the tail vain was mixed with 500 ml of ookinete medium
(RPMI1640 containing 25 mM HEPES, 20% FCS, 100 mM
xanthurenic acid, pH 7.4) and examined using an improved
Neubauer hemocytometer 12 min later. The number of erythro-
cytes and exflagellating microgametocytes were counted and
expressed as a percentage of all microgametocytes as indepen-
dently determined from stained blood films.
To assess ookinete formation 100 ml infected blood were
cultured in 10 ml ookinete medium at 19uC for 20 h. Live
staining with a Cy3-congugated mouse monoclonal antibody
against the P28 protein labeled banana shaped ookinetes and
undifferentiated macrogamete derived parasites, whose shape was
assessed by microscopy and recorded for at least 100 cells per
sample. For transmission studies ,200 female A. stephensi
mosquitos were allowed to feed on the same infected mice.
Exflagellation assays, ookinete cultures and mosquito feeds were
performed using the same animals (three per strain) on day three
of the infection.
Midguts from 20 fed mosquitoes from each cage were dissected
in PBS 7 and 14 days after feeding, examined for oocysts,
photographed and analysed as described [65]. On day 21 post
feeding salivary glands from 20 mosquitoes per group were
dissected, homogenized and sporozoites quantified in a hemocy-
tometer. Finally, on day 23 the remaining mosquitoes were
allowed to feed on uninfected mice that had been pre-treated with
phenylhydrazine two days before. In parallel the salivary glands
from 20 mosquitoes were homogenized and injected intravenously
into different mice. All animals were observed for 14 days and the
time of parasite appearance in the blood was noted.
Metabolite extraction and analysis of T. gondii
tachyzoites
Metabolite extraction and analysis of T. gondii tachyzoites was
performed as previously described [20]. Intracellular and egressed
tachyzoites (26108 cell equivalents) were extracted in chloroform/
methanol/water (1:3:1 v/v containing 1 nmol scyllo-inositol or
5 nmol 13C-valine as internal standard for GC-MS and LC-MS,
respectively) for 1 h at 4uC, with periodic sonication. For GC-MS
analysis polar and apolar metabolites were separated by phase
partitioning. Polar metabolite extracts were derivitised by
methoximation and trimethylsilylation (TMS) and analysed by
GC-MS as previously described [66]. For LC-MS analysis,
monophasic metabolite extracts were analysed directly with a
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ZIC-pHILIC - Orbitrap platform and data analysed with IDEOM
as previously described [19,67]. All metabolites were identified by
comparison of retention time and exact mass (LC-MS) or mass
spectra (GC-MS) with authentic chemical standards, with the
exception of 2-hydroxyethyl-TPP putatively identified by exact
mass (,1 ppm) and predicted retention time based on a
quantitative structure-retention relationship model for this chro-
matographic method [68].
Stable isotope labelling of T. gondii tachyzoites, P.
berghei-infected and uninfected RBCs
T. gondii: stable isotope labelling, metabolite extraction, and
GC-MS analysis was performed for polar metabolites, as
previously described [20]. Briefly, infected HFF or freshly egressed
tachyzoites were incubated in low-glucose, glutamine-free
DMEM, supplemented with either 13C-U-glucose, 13C-U-gluta-
mine, 13C-U-leucine or 13C-U-leucine/13C-U-isoleucine/13C-U-
valine (final concentration 8 mM, Spectra Stable Isotopes).
Parasites were harvested after 4 h and metabolites extracted as
above. Changes in the mass isotopologue abundances of key
intermediates in central carbon metabolism were assessed by GC-
MS or LC-MS analysis. The level of labelling of individual
metabolites was calculated as the percent of the metabolite pool
containing one or more 13C atoms after correction for natural
abundance and amount of 13C-carbon source compared to 12C-
carbon source in the culture medium (as determined by GC-MS
analysis). The mass isotopologue distributions (MIDs) of individual
metabolites were corrected for the occurrence of natural isotopes
in both the metabolite and, in GC-MS experiments, the
derivatisation reagent [69]. An untargeted metabolome-wide
isotope analysis was performed on high resolution LC-MS data
to detect all labelled metabolic products of 13C-U-glucose or 13C-
U-leucine/13C-U-isoleucine/13C-U-valine according to the meth-
od previously described [70].
P. berghei: stable isotope labelling, metabolite extraction, and
GC-MS analysis was adapted from the above protocol. Blood
(1 mL) from individual mice infected (iRBC) with WT or Pbe1a_ko
parasites (blood at equivalent parasitemia of ,4%) was collected
and all white cells removed by passage of the blood over cellulose
CF11 columns. Parasites were cultured for maturation in vitro for
5 h (RPMI1640 containing 25 mM HEPES [Sigma], 0.5%
Albumax, 0.2 mM hypoxanthine [pH 7.5], 25 mg/ml Gentamy-
cin), before addition of 8 mM 13C-U-glucose, 13C-U-glutamine, or
13C-U-leucine as required. After 5 h of labelling, cultures were
rapidly transferred to a 50 mL centrifuge tube and cellular
metabolism quenched as above and schizont-infected RBCs
(iRBCs) were purified from uninfected and ring-infected RBCs
on Nycodenz gradient, at 4uC. iRBCs and uninfected RBCs
(control) were pelleted by centrifugation (8006 g, 10 min, 4uC),
washed three times with ice-cold PBS, extracted and analysed as
above.
In vitro keto-acid dehydrogenase enzyme assay
Cell extracts were prepared from 108 freshly egressed T. gondii
tachyzoites by hypotonic lysis with ice-cold lysis buffer (1 mM
NaHEPES (pH 7.4, Sigma), 2 mM ethylene glycol tetraacetic acid
(Sigma), 2 mM dithiothreitol (Biovectra)) for 10 min on ice, in the
presence of EDTA-free protease inhibitors (complete, Roche).
Extracts were incubated with 0.5 mM or 2 mM of the test keto-
acid (4-methyl-2-oxopentanoate, 3-methyl-2-oxobutanoate or py-
ruvate) in the presence of cofactors (5 mM NAD+, 1 mM CoA,
0.1 mM Thiamine-PP, 0.1 mM FAD and 0.05 mM lipoic acid) in
200 mL MgCl2/KH2PO4 (1.3 mM/33 mM) buffer (pH 7) at 37uC
for 2 h (n= 2). Samples (20 mL) were extracted in 80 mL
methanol/acetonitrile (1:3) and analysed by LC-MS (pHILIC-
QTOF) as described in the metabolomics methods. 3-methylbu-
tanoyl-CoA, 2-methylpropanoyl-CoA and acetyl-CoA were quan-
tified by reference to calibration curves of authentic standards in
sample matrix (extracted lysates). Additional TPP intermediates
were not quantified due to lack of authentic reference standards,
and data are expressed as LC-MS peak areas. The raw high-
resolution MS data were interrogated for the occurrence of other
possible metabolic products derived from the branched chain keto-
acids or acyl-CoAs, and none were detected. Additional controls
were analysed to validate the assay including substrate-free and
cofactor-free incubations, technical replicates of pooled samples
for LC-MS quality control and matrix controls for RH and
Tge1a_ko samples (data not shown).
Supporting Information
Figure S1 Generation and characterization of T.gondii
BCKDH-E1a knock-out. (A) This scheme represents the double
homologous recombination approach used to generate a direct
knockout of the TgBCKDH-E1a. FS, flanking sequence. (B)
Genomic PCR confirming the integration in 5’ and 3’ of the
HXGPRT selection cassette and loss of the cds of TgBCKDH-E1a
using primers indicated in panel A and Table S2.
(EPS)
Figure S2 LC-MS analysis of acetyl-CoA biosynthesis in
T. gondii. Raw LC-MS high resolution mass spectra for acetyl-
CoA (retention time= 13.55 min on pHILIC column) from RH
and Tge1a_ko T. gondii labeled with (A) 13C-U-glucose and (B) 13C-
U-valine, 13C-U-leucine and 13C-U-isoleucine (BCAA). 13C2-
labeled acetyl-coA (M+2.007) is only observed in 13C-U-glucose-
labelled wild-type cells. The (M+1) and (M+3) peaks represent the
natural isotopomer abundances of unlabelled (C23H38N7O17P3S)
and 13C2-labeled (
13C2C21H38N7O17P3S) acetyl-coA, respectively.
(EPS)
Figure S3 Alignment of BCKDH-E1a subunits. (A) Protein
alignment comparing the TgBCKDH-E1a subunit with the
apicoplast TgPDH-E1a of T. gondii. Boxed residues are the same
as in (B). Amino acids boxed light blue are similar, dark blue are
identical between both sequences. TgPDH-E1a consists of an N-
terminal apicoplast targeting sequence without homology to
TgBCKDH-E1a. Starting from amino acid 170 of TgPDH-E1a
sequence identity between both proteins is 25%. (B) Protein
alignment comparing the BCKDH-E1a subunit of T. gondii
(TGME49_039490), P. berghei (PBANKA_141110), P. falciparum
(PF3D7_1312600), P. vivax (PVX_122460), Homo sapiens (P12694),
Bacillus subtillis (P37940), Pseudomonas putida (P09060) and Thermus
thermophiles (Q5SLR4). Sequences were aligned with MUSCLE 3.7
[72] and displayed with Jalview 2 [73]. The black boxed residues
are the putative phosphorylation site (Ser 292 is phosphorylated in
the human protein; [74]) and those in red mark an important
conserved tyrosine (Tyr113 in the human protein), essential for
switching between two conformational states, thereby modulating
the reactivity of the ThPP cofactor [75]. (C) Tabulation of
sequence identities in % of aligned BCKDH proteins in (C)
starting from aa 60 of TgBCKDH-E1a.
(EPS)
Figure S4 Generation and characterization of
PbBCKDH-E1a knock-out strain and complementation
with PfBCKDH-E1a. (A) Schematic representation of the double
homologous recombination strategy used to generate Pbe1a_ko.
The recombination event led to the replacement of PbBCKDH-E1a
coding region with a TgDHFR selection cassette. FS, flanking
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sequence. (B) Parasitaemia was followed daily in mice infected
with WT (blue line) or Pbe1a_ko (red line). Each line corresponds
to the parasitaemia of one mouse. 4 mice were infected per
condition. Related to Figure 4C. (C) Schematic representation of
the knock-in strategy in the promoter region of PbBCKDH-E1a
(pPbE1a) to complement the Pbe1a_ko with the P. falciparum
BCKDH-E1a subunit. FS, flanking sequence. The star represents
the linearization site of the complementation plasmid containing
the hDHFR selection cassette. (D) Genomic PCR analysis
confirming the integration in 5’ and 3’ of TgDHFR cassette and
loss of the open reading frame of PbBCKDH-E1a to generate
Pbe1a_ko. PCR analysis confirmed that the recombination event
that placed the PfBCKDH-E1a open reading frame under the
control of the PbBCKDH-E1a promoter in the Pbe1a_ko strain to
generate Pbe1a_ko+Pfe1a. Primers used are indicated in panel A
and C and Table S2. (E) Total cell lysates from mixed population
of parasitic stages for P. falciparum Pf3D7, Pb wild-type, Pbe1a_ko
and Pbe1a_ko+Pfe1a were analysed by western blot. Expression of
BCKDH-E1a (shown by the arrow) was assessed using cross-
reacting anti-PfBCKDH-E1a. Profilin was used as loading control.
* represents an unspecific band, the intensity of which varied upon
sample preparation. (F) Parasitaemia in mice infected with wild
type (blue) or Pbe1a_ko+ Pfe1a (green) showing complementation
of the growth defect observed in Pbe1a_ko. Error bars show the SD
of three mice per condition.
(PDF)
Figure S5 P. berghei, but not RBCs, catabolizes glucose
and glutamine in a complete TCA cycle. Wild type (wt) or
Pbe1a_ko (ko) P. berghei-infected RBCs and uninfected RBCs (RBC)
were suspended in medium containing either (A) 13C-U-glucose,
13C-U-glutamine, or (B) 13C-U-leucine for 5 hr. Incorporation of
13C into selected polar metabolites was quantified by GC-MS and
levels (mol percent containing one or more 13C carbons) after
correction for natural abundance are represented by heat plots.
n.d., not detected.
(EPS)
Figure S6 Acetate partially rescues growth defect of
P.berghei BCKDH null mutants. (A) Related to Fig. 6.
Following in vitro invasion of normocytes with WT or Pbe1a_ko,
parasites were allowed to mature in vitro for 20 h in media
supplemented or not with 5 mM acetate. Replication of DNA
content was taken as measure of parasite maturation. DNA was
labelled using Vybrant DyeCycle Ruby Stain and fluorescence
intensity was measured by flow cytometry. Highlighted in green is
the ring/parasites degenerated early in their development fraction
while trophozoite/schizont stage iRBCs are highlighted in orange.
Each line corresponds to a biological replicate.
(EPS)
Table S1 Different subunits of the BCKDH complex and
the mitochondrial pyruvate carrier.
(PDF)
Table S2 Primers used in this study.
(PDF)
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